Field of the Invention
This application relates in general to a securement device for a medical article. More particularly, the device disclosed herein can interconnect various medical articles with one another. Additionally, the device can releasably secure to a patient's skin.
Description of the Related Art
It is common in the treatment of patients to utilize catheters to introduce fluids and medications directly into the patient or to withdraw fluids from the patient. When introducing fluid into a patient, the fluid (e.g., parenteral liquid, medication, etc.) typically drains from a container positioned above the patient to feed under gravity or is delivered via an infusion pump. The fluid flows through a medical line and into, for example, an indwelling catheter inserted into the patient. The inserted medical article and medical line are often releasably secured to each other by a conventional T-connection.
A T-connection generally includes a male connector with a tapered conical portion that is adapted to fit into a correspondingly shaped receptacle of a female connector (i.e., a hub). A spin nut is commonly disposed on the male connector and is rotatable relative to the tapered conical portion. The spin nut includes internal threads adapted to engage external threads on the female connector to lock the connectors together. When properly engaged, the conical portion fits tightly within the receptacle to produce a sealed interconnection.
The systems, devices, and methods of the present invention have several features, no single one of which is solely responsible for its desirable attributes. Without limiting the scope of this invention as expressed by the claims which follow, its more prominent features will now be discussed briefly. After considering this discussion, and particularly after reading the section entitled “Detailed Description of Certain Embodiments,” one will understand how the features of this invention provide several advantages over existing medical devices.
In one embodiment, a medical article securement system includes a retainer that has a first lumen defined between a first port and a second port, and a second lumen fluidly connected to the first lumen. The system further includes an anchor pad that has an upper surface and a lower surface. At least a portion of the lower surface is covered by adhesive. The system further comprises interengaging structure releasably securing the retainer to the anchor pad.
In another embodiment, a method of securing a medical article to a patient includes providing a retainer having a first lumen defined between a first port and a second port, and a second lumen fluidly connected to the first lumen. The method further includes providing an anchor pad having an upper surface and a lower surface. At least a portion of the lower surface is covered by adhesive. The method further includes releasably engaging the retainer to the anchor pad.
In yet another embodiment, a device for fluidly connecting a plurality of medical articles to an anchor includes a first lumen, a second lumen, a manifold connecting the first lumen to the second lumen, and at least one guiderail configured to slidably engage with the anchor.
The above mentioned and other features of the invention will now be described with reference to the drawings of several embodiments of the present securement systems. The illustrated embodiments of the securement systems are intended to illustrate, but not to limit the invention. The drawings contain the following figures:
The following description and examples illustrate certain embodiments of the present securement systems disclosed in the context of a catheterization system, and in particular in the context of a catheterization system utilizing a T-connector securement device. The catheterization system can include a catheter and one or more medical lines. More specifically, the embodiments relate to a securement system and related techniques that secure an interconnection of medical articles relative to a patient. Although, the embodiments of the securement systems are illustrated with intravenous catheters and medical lines, it will be understood by those of skill in the art in view of the present disclosure that the securement systems described herein can be used with other types of medical articles, including, but not limited to catheters and catheter hubs of various design, either with or without connectors or extension sets, such as central venous catheters, peripherally inserted central catheters, hemodialysis catheters, Foley catheters, as well as other designs of catheter hubs and catheter adaptors. Other medical articles may include surgical drainage tubes, feeding tubes, chest tubes, nasogastric tubes, rectal drains, external ventricular drains, chest tubes, any other sort of fluid supply or medical lines, connector fittings, and scopes, as well as electrical wires or cables connected to external or implanted electronic devices or sensors. The medical articles can each be a single medical article or a combination of medical articles.
One skilled in the art may also find additional applications for the devices, systems, and methods disclosed herein. Accordingly, the illustration and description of the securement systems in connection with a catheter and one or more medical lines is merely exemplary of one possible application of the securement systems and techniques disclosed.
The securement systems described with reference to the figures are especially adapted to arrest at least longitudinal movement of a medical article relative to an insertion site. The securement systems accomplish this without meaningfully impairing (i.e., substantially occluding) fluid flow through a lumen of the medical article or impairing insertion of a medical article, for example, a catheter. The securement systems may include retention mechanisms, for example, threaded fittings and male or female luer-lock connection fittings, to releasably secure one or more medical articles to the securement device.
With reference now to
The securement device 110 includes one or more channels 120. For embodiments that include two or more channels, the two channels may be interconnected within the securement device 110. For example, the illustrated securement device 110 includes a first channel 120 defining an internal lumen and a second channel 130 defining an internal lumen. The two lumens interconnect within the securement device 110. In this way, the securement device 110 fluidly interconnects two or more medical articles attached to the securement device 110. The first channel 120 includes an inlet port 122 and an outlet port 124. The second channel 130 includes an inlet port 132 at a first end and interconnects with the first channel 120 at a second end. In this way, the ports 122, 124, 132 are fluidly interconnected with one another. Each of the channels 110, 120 may have additional inlet and outlet ports depending on factors including the number of medical articles, desired flow arrangement through the securement device 110, the intended application of the securement device 110, and desired mixing of fluids through the securement device 110.
The anchor pad 102 is configured to be secured to a patient's skin and can include a release liner 104 disposed over an adhesive layer 106. As will be described in further detail below, in this way, medical articles can be interconnected with one another via the securement device 110 with the assembled securement device and medical articles being releasable from the anchor pad 102.
To assist in the description of the components of embodiments of the securement systems, the following coordinate terms are used, consistent with the coordinate axes illustrated in
Anchor Pad
As can be seen in
In some embodiments, the channel 108 extends from a first lateral side of the anchor pad 102 and terminates before reaching the second lateral side of the anchor pad 102. In such embodiments, the channel 108 forms an abutment surface 107 which prevents further lateral movement of the securement device 110 once the securement device 110 abuts against the surface 107. In other embodiments, the channel 108 extends through the anchor pad 102 from one lateral side to the other. Those of skill in the art will appreciate that the channel 108 can be oriented differently with respect to the coordinate axes of the securement system 100. For example, the channel 108 can extend longitudinally or at an angle relative to the longitudinal and lateral axes of the anchor pad 102.
The size and shape of the anchor pad 102 can vary depending on where the anchor pad 102 is intended to be positioned on a patient. For example, in some embodiments the securement system 100 may be intended for placement on a patient's hand and in other embodiments, the securement system 100 may be intended for placement on a different part of a patient, for example, a patient's back. The anchor pad 102 may be any size or shape that allows attachment of the anchor pad 102 to a patient's skin and that is configured to support at least the securement device 110. In the illustrated embodiment, the size and shape of the anchor pad 102 is selected to support at least two medical lines and a catheter. In some embodiments, the anchor pad 102 is configured to support more than two medical lines and/or additional medical articles, for example, two extension sets and two medical lines. In such an embodiment, the size and shape of the anchor pad 103 may be increased to provide support for the additional medical line.
The anchor pad 102 has a lower adhesive surface 106 for adhering to the skin of a patient and an upper surface 103. The anchor pad 102 is configured to support at least the securement device 110, as described above. In combination, the lower adhesive surface 106, the upper surface 103, and possibly one or more intermediate layers may comprise a laminate structure. A suitable laminate that comprises a foam or woven material with an adhesive layer is available commercially from Avery Dennison of Painsville, Ohio. The anchor pad 102 may be configured as a flexible structure which conforms to the surface of a patient's skin.
The lower adhesive surface 106 or layer may be a medical-grade adhesive and can be either diaphoretic or nondiaphoretic, depending upon the particular application. The lower adhesive surface 106 may have additional types of medical adhesives laminated thereto. In some embodiments, the lower adhesive layer 106 comprises an anti-bacterial or anti-microbial material. For example, the lower adhesive layer may comprise one or more oligodynamic metal salts or oxides, or a combination of salts and oxides. In some embodiments, the lower adhesive layer 106 comprises a silver material, for example a silver salt, colloid, or complex. The adhesive layer 106 may be a solid layer or may be configured as an intermittent layer such as in a pattern of spots or strips. The lower adhesive layer 106 can be applied to the anchor pad 102 during manufacture, and may be further covered with a release liner 104.
The upper surface 103 may comprise a foam (e.g., closed-cell polyethylene foam) or woven material (e.g., tricot) layer. A surface of the foam or woven material layer can constitute the upper surface 103 of the anchor pad 102. In the alternative, the upper surface 103 may comprise an upper paper or other nonwoven cloth layer, and an inner foam layer may be placed between the upper surface 103 and lower adhesive layer 106.
A removable release liner 104 may cover the lower adhesive layer 106 before use. The release liner 104 may resist tearing and be divided into a plurality of pieces to assist removal of the release liner and ease attachment of the anchor pad 102 to a patient's skin. The release liner 104 may be divided into two adjacent pieces. The liner 104 may be made of a paper, plastic, polyester, or similar material. For example, the release liner 104 may comprise a material made of polycoated, siliconized paper, or another suitable material such as high density polyethylene, polypropylene, polyolefin, or silicon coated paper.
Securement Device
With reference now to
In some embodiments, the first channel 120 is perpendicular to the second channel 130 and in other embodiments, the first and second channels intersect to form obtuse or acute angles therebetween. In one embodiment, the first channel 120 extends at an angle of between about 5° and about 30° to a bottom planar surface 114 of the securement device 110 to facilitate the insertion of a connected catheter to a patient at a desired angle, for example, 7°.
The outlet port 124 of the first channel 120 is configured to engage the distal end of a hub of a catheter or another connector. The inlet port 122 of the first channel 120 can include a male luer-lock connection fitting and a spin nut configured to connect to a medical line or a female luer-lock connection of another medical article, for example, an extension set. Similarly, the inlet port 132 of the second channel 130 can include a male luer-lock connection fitting and a spin nut configured to connect to a medical line or a female luer-lock connection of another medical article.
In some embodiments, the outlet port 124 is connected to an intravenous catheter and the inlet ports 122, 132 are connected to separate medical lines. Such a configuration advantageously provides for the fluid connection of two or more channels for introduction of two or more fluids into the body of a patient. For example, a first medical line can be fluidly coupled to inlet port 122 in order to introduce a first fluid to a patient through a catheter and a second medical line can be fluidly coupled to inlet port 132 in order to introduce a second fluid to the patient through the same catheter. In another example, the interconnection or plenum of the first and second channels 120, 130 provides for the infusion of fluid through a first inlet port 122 and aspiration and/or flushing through a second inlet port 132. In other embodiments, a catheter is connected to outlet port 124, a medical line is connected to inlet port 122, and inlet port 132 is unused or capped.
In some embodiments, the securement device 110 can include one or more valves, membranes, or septums. For example, the first channel 120 and/or second channel 130 can optionally include one or more integral one-way valves to permit the passage of fluid therethrough in a single direction, for example, in a direction toward the patient. The inlet ports 122, 132 can also optionally include needle stick membranes or septums configured to allow a syringe needle to penetrate through the membrane and into the respective channels 120, 130. For example, one or more fluids can enter the interconnection or plenum formed in the securement device 110 via a needle stick membrane and can subsequently be introduced into a patient through an intravenous catheter fluidly connected to the outlet port 124.
The body of the securement device 110 can comprise various shapes configured to house an interconnection of the first and second channels 120, 130. For example, the body of the securement device 110 can be substantially bell shaped with a generally planar bottom surface 114 as illustrated in
As shown in
The guiderails 112 can comprise various shapes that are complimentary to corresponding grooves or tracks in the anchor pad 102. For example, the securement device 110 can include two substantially L-shaped rails that are each configured to be received within, and slidably engage, a groove 109 in the anchor pad 102. In this way, the guiderails 112 releasably couple the securement device 110 to the anchor pad 102 while permitting the securement device 110 to slide or translate in at least two directions relative to the anchor pad 102. As discussed above with reference to
The securement system 100 can optionally include one or more timers 150 so as to be accessible by the healthcare provider. In some embodiments, the timer 150 is disposed on an outer surface of the securement device 110 and optionally includes a display 152.
The timer 150 may be configured to measure elapsed time and can be activated manually by a user, remotely by a user, and/or by a triggering event, for example, the connection of one or more medical articles to the securement device 110 and/or the passage of fluid through a lumen in the securement device 110. The timer 150 indicates a time-based characteristic of the medical article or line, such as, for example, the length of time the medical article or line has been in place on the patient. In some implementations, the timer 150 measures a flow rate of fluid into the patient and compares the measured flow rate to a target flow rate. Thus, the timer 150 may be used to verify that the lumens of the medical lines, securement device, and/or catheter are not occluded or partially occluded.
The timer 150 can be flexible or rigid, and can be disposed directly on the securement device 110. In some embodiments, the timer 150 is disposed on the anchor pad 102. By prominently positioning the timer 150, the timer can provide an easy-to-use and reliable visual indicator of elapsed time. The timer 150 can be a battery-operated timer or a chemically-active timer. Embodiments of a chemically active timer 150 can change color or provide another visual response when exposed to air or a selected chemical for a given length of time.
In some implementations, the timer 150 is activated by a healthcare provider at generally the same time a catheter is connected to the outlet port 124 (or just prior to or just after insertion). The activated timer 150 may then provide a visual indication of the length of time elapsed or period since the catheter was connected to the securement device 110. The timer 150 may provide, in addition to or instead of a visual response, an audible indication or alarm of a given length of time. For example, the timer 150 may beep, chirp, or otherwise emit sound indicative of a time-based characteristic.
The period between indication outputs from the timer 150 can be fixed or variable. For example, the timer 150 can provide an indication after a first time period and then provide a second indication after a second time period. The first and second time periods may have the same or different durations. The first indication may be the same or different than the second indication. For example, the timer 150 can provided an audible indication after the first time period and a visual indication after the second time period. Thus, the timer 150 can be used to signal when the medical line should be replaced and/or re-sited.
The securement device 110 can optionally include one or more pressure sensors or transducers configured to measure the pressure of an infusate flowing through the securement device 110. For example, the securement device 110 can include a pressure sensor coupled with the inlet or outlet ports 122, 132, 124 to measure the pressure of flowing fluid. In some embodiments, a pressure transducer provides an audible or visual indication or alarm when the pressure of the infusate exceeds a given threshold or is below a given threshold. For example, a pressure transducer may be configured to provide an audible alarm when pressure changes as a function of infiltration or extravasation. A spike or increase in the sensed pressure may indicate that the vein has been infiltrated.
The securement device 110 can optionally include one or more flow sensors or meters configured to sense a rate of fluid flow through the first channel 120 and/or second channel 130. For example, the securement device 110 can include a flow sensor coupled with the outlet port 124 to measure a rate of infusate flow therethrough. The one or more flow sensors can be configured to provide an audible or visual indication or alarm when a flow rate through the first channel 120 and/or second channel 130 exceeds a given threshold or is below a given threshold. For example, a flow sensor can be configured to provide an audible alarm when a flow rate through the connection device 110 is below a certain threshold such that the patient is not receiving sufficient fluid or infusate delivery.
The optional timers, pressure transducers, and/or flow sensors can include stored memory elements including one or more libraries of stored settings. For example, drug or medication libraries with stored settings relating to each individual drug or medication can be stored on memory elements to provide threshold values to the optional timers, pressure transducers, and/or flow sensors. In some embodiments, such memory elements can be configured to trigger an audible or visual indication or alarm when a given dosage has been met and/or when a pressure or flow characteristic of a given infusate deviates from an expected value.
Method of Use
The following discussion of the method of use will be with reference to
A healthcare provider typically begins the catheterization process by positioning the catheter hub 202 at a desired location above a vein. The healthcare provider introduces a needle or other stylus through a cannula portion of the catheter hub 202 and into the skin of the patient at a desired incident angle. For intravenous use, the catheter hub 202 commonly has an incident angle of approximately 7°. The healthcare provider then inserts the cannula of the catheter hub 202 into the patient and withdraws the needle or stylus. Part of the catheter hub 202 remains exposed above the skin. The healthcare provider can then connect the distal end of the catheter hub 202 to the outlet port 124 of the securement device 110. In some embodiments, the outlet port 124 can include internal threads to allow the hub 202 to be threadably secured to the outlet port 124. As discussed above, upon introducing the catheter into the patient's vein, the timer 150 may be manually, automatically, and/or remotely activated to measure an elapsed time. In some embodiments, the timer 150 may be activated upon connection of the catheter hub 202 to the securement device 110 or upon connection of a medical line to the catheter hub 202 via the securement device 110.
With the securement device 110 and the catheter hub 202 connected to one another, the healthcare provider may next align the guiderails 112 of the securement device 110 with the grooves 109 in the recess 108 of the anchor pad 102. With the guiderails 112 aligned with the grooves 109, the healthcare provider slides the securement device 110 relative to the anchor pad 102 to secure the securement device 110 to the anchor pad 102 via the engagement between the grooves 109 and the guiderails 112. As shown in
Before or after the securement device 110 is slidably engaged with, and releasably secured to, the anchor pad 102, the healthcare provider removes the releasable liner 104 which initially covers the adhesive lower layer of the anchor pad 102. The healthcare provider attaches the pad 102 to the patient's skin proximate to the indwelling catheter. The healthcare provider positions the anchor pad 102 over the placement site and places the exposed bottom layer against the patient's skin 200 so as to adhere the anchor pad 102 to the patient. Light pressure over the anchor pad 102 and/or securement device 110 assures good adhesion between the anchor pad 102 and the patient's skin 200. The anchor pad 102, due to its flexibility, conforms to the contours of the patient's skin. Additionally, the anchor pad 102 can be attached to the patient before the securement device 110 is secured to the anchor pad 102. With the securement device 110 and the anchor pad 102 slidably engaged with one another, and the anchor pad 102 adhered to the patient's skin 200, movement of the catheter 202 may be limited in at least the longitudinal direction.
The healthcare provider may then connect additional medical articles to the securement device 110. For example, the healthcare provider may connect a primary medical line 206 to inlet port 122 to establish a fluid connection between the catheter hub 202 and the medical line 206. The healthcare provider may optionally connect a secondary medical line 204 to inlet port 132 to fluidly connect the medical line 204 to the catheter hub 202 via the securement device 110. Alternatively, the inlet port 132 may be used to aspirate or flush the catheter hub 202, medical line 206, or securement device 110. In this way, the components of catheterization system including the catheter hub 202 and the medical lines 204, 206 can be fluidly interconnected by the securement device 110 and the resultant interconnection can be secured relative to the patient's skin 200 by the securement device 110 and the anchor pad 102.
In some embodiments, the healthcare provider may dispose a sterile dressing over the insertion site and at least a portion of the catheter hub 202. The optional dressing can be attached to and/or integrated with the anchor pad 102 or securement device 110. The dressing can be configured to fold, bend, or rotate down over the insertion site area.
The present securement systems thus provide a sterile, needle-, and tape-free way to fluidly connect components of a catheterization system and to secure the interconnection to patient. These systems eliminate the use of tape, and if prior protocol required suturing, they also eliminate accidental needle sticks, suture-wound-site infections and scarring. In addition, the systems can be configured to be used with any of a wide variety of catheters, fittings, tubes, wires, and other medical articles. Patient comfort is also enhanced and application time is decreased with the use of the present securement systems.
It is to be noted that the figures provided herein are not drawn to any particular proportion or scale, and that many variations can be made to the illustrated embodiments. Those of skill in the art will recognize that the disclosed aspects and features shown herein are not limited to any particular embodiment of a stabilization system, and stabilization systems that include one or more of the features herein described can be designed for use with a variety of medical articles.
The various embodiments of the securement systems described above in accordance with the present invention thus provide a means to releasably secure a connector fitting or extension set to a patient. An insertion site of a catheter attached to the connector fitting or extension set may be covered with an integrated dressing.
Of course, it is to be understood that not necessarily all objects or advantages may be achieved in accordance with any particular embodiment of the invention. Thus, for example, those skilled in the art will recognize that the invention may be embodied or carried out in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other objects or advantages as may be taught or suggested herein.
Furthermore, the skilled artisan will recognize the interchangeability of various features from different embodiments. In addition to the variations described herein, other known equivalents for each feature can be mixed and matched by one of ordinary skill in this art to construct stabilization systems and techniques in accordance with principles of the present invention.
Although this invention has been disclosed in the context of certain embodiments and examples, it will be understood by those skilled in the art that the present invention extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses of the invention and obvious modifications and equivalents thereof. Thus, it is intended that the scope of the present invention herein disclosed should not be limited by the particular disclosed embodiments described above, but should be determined only by a fair reading of the claims that follow.
This application claims priority under 35 U.S.C. § 119(e) to U.S. Provisional Patent Application Ser. No. 61/452,014, filed Mar. 11, 2011, and entitled MEDICAL ARTICLE SECUREMENT DEVICE, which is hereby expressly incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
2402306 | Turkel | Jun 1946 | A |
2525398 | Collins | Oct 1950 | A |
2533961 | Rousseau et al. | Dec 1950 | A |
3046984 | Eby | Jul 1962 | A |
3064648 | Bujan | Nov 1962 | A |
3167072 | Stone et al. | Jan 1965 | A |
3194235 | Cooke | Jul 1965 | A |
3245567 | Knight | Apr 1966 | A |
3288137 | Lund | Nov 1966 | A |
3394954 | Sarns | Jul 1968 | A |
3493238 | Ludwig | Feb 1970 | A |
3529597 | Fuzak | Sep 1970 | A |
3589361 | Loper et al. | Jun 1971 | A |
3630195 | Santomieri | Dec 1971 | A |
3677250 | Thomas | Jul 1972 | A |
3686896 | Rutter | Aug 1972 | A |
3766915 | Rychlik | Oct 1973 | A |
3812851 | Rodriguez | May 1974 | A |
3817240 | Ayres | Jun 1974 | A |
3826254 | Mellor | Jul 1974 | A |
3834380 | Boyd | Sep 1974 | A |
3856020 | Kovac | Dec 1974 | A |
3863631 | Baldwin | Feb 1975 | A |
3900026 | Wagner | Aug 1975 | A |
3901226 | Scardenzan | Aug 1975 | A |
3906946 | Nordstrom | Sep 1975 | A |
3920001 | Edwards | Nov 1975 | A |
3934576 | Danielsson | Jan 1976 | A |
3942228 | Buckman et al. | Mar 1976 | A |
3973565 | Steer | Aug 1976 | A |
4004586 | Christensen et al. | Jan 1977 | A |
D243477 | Cutruzzula et al. | Feb 1977 | S |
4020835 | Nordstrom et al. | May 1977 | A |
4037599 | Raulerson | Jul 1977 | A |
4059105 | Cutruzzula et al. | Nov 1977 | A |
4079738 | Dunn et al. | Mar 1978 | A |
4082094 | Dailey | Apr 1978 | A |
4114618 | Vargas | Sep 1978 | A |
4116196 | Kaplan et al. | Sep 1978 | A |
4123091 | Cosentino et al. | Oct 1978 | A |
4129128 | McFarlane | Dec 1978 | A |
4133312 | Burd | Jan 1979 | A |
4142527 | Garcia | Mar 1979 | A |
4161177 | Fuchs | Jul 1979 | A |
D252822 | McFarlane | Sep 1979 | S |
4170993 | Alvarez | Oct 1979 | A |
4193174 | Stephens | Mar 1980 | A |
4194504 | Harms et al. | Mar 1980 | A |
D256162 | Haerr et al. | Jul 1980 | S |
4224937 | Gordon | Sep 1980 | A |
4230109 | Geiss | Oct 1980 | A |
4250880 | Gordon | Feb 1981 | A |
4275721 | Olson | Jun 1981 | A |
4314568 | Loving | Feb 1982 | A |
4316461 | Marais et al. | Feb 1982 | A |
4324236 | Gordon et al. | Apr 1982 | A |
4326519 | D'Alo et al. | Apr 1982 | A |
4333468 | Geist | Jun 1982 | A |
4362156 | Feller, Jr. et al. | Dec 1982 | A |
4392853 | Muto | Jul 1983 | A |
4397647 | Gordon | Aug 1983 | A |
4398757 | Floyd et al. | Aug 1983 | A |
4405163 | Voges et al. | Sep 1983 | A |
4405312 | Gross et al. | Sep 1983 | A |
4435174 | Redmond et al. | Mar 1984 | A |
4435175 | Friden | Mar 1984 | A |
4439193 | Larkin | Mar 1984 | A |
D273993 | Schulte et al. | May 1984 | S |
4449975 | Perry | May 1984 | A |
4453933 | Speaker | Jun 1984 | A |
4470410 | Elliott | Sep 1984 | A |
4474559 | Steiger | Oct 1984 | A |
4480639 | Peterson et al. | Nov 1984 | A |
4484913 | Swauger | Nov 1984 | A |
4516968 | Marshall et al. | May 1985 | A |
4517971 | Sorbonne | May 1985 | A |
4561857 | Sacks | Dec 1985 | A |
4563177 | Kamen | Jan 1986 | A |
4585435 | Vaillancourt | Apr 1986 | A |
4585444 | Harris | Apr 1986 | A |
4631056 | Dye | Dec 1986 | A |
4632670 | Mueller, Jr. | Dec 1986 | A |
4633863 | Filips et al. | Jan 1987 | A |
4645492 | Weeks | Feb 1987 | A |
4650473 | Bartholomew et al. | Mar 1987 | A |
4660555 | Payton | Apr 1987 | A |
4666434 | Kaufman | May 1987 | A |
4669458 | Abraham et al. | Jun 1987 | A |
4693710 | McCool | Sep 1987 | A |
4711636 | Bierman | Dec 1987 | A |
4723948 | Clark et al. | Feb 1988 | A |
4737143 | Russell | Apr 1988 | A |
4742824 | Payton et al. | May 1988 | A |
4743231 | Kay et al. | May 1988 | A |
4752292 | Lopez et al. | Jun 1988 | A |
4792163 | Kulle | Dec 1988 | A |
4795429 | Feldstein | Jan 1989 | A |
4826486 | Palsrok et al. | May 1989 | A |
4834702 | Rocco | May 1989 | A |
4834716 | Ogle, II | May 1989 | A |
4838858 | Wortham et al. | Jun 1989 | A |
D302304 | Kulle et al. | Jul 1989 | S |
4846807 | Safadago | Jul 1989 | A |
4852844 | Villaveces | Aug 1989 | A |
4857058 | Payton | Aug 1989 | A |
4863432 | Kvalo | Sep 1989 | A |
4878897 | Katzin | Nov 1989 | A |
4880412 | Weiss | Nov 1989 | A |
4895570 | Larkin | Jan 1990 | A |
4897082 | Erskine | Jan 1990 | A |
4898587 | Mera | Feb 1990 | A |
4919654 | Kalt | Apr 1990 | A |
4934375 | Cole et al. | Jun 1990 | A |
4941882 | Ward et al. | Jul 1990 | A |
4955864 | Hajduch | Sep 1990 | A |
4966582 | Sit et al. | Oct 1990 | A |
4976698 | Stokley | Dec 1990 | A |
4976700 | Tollini | Dec 1990 | A |
4981469 | Whitehouse et al. | Jan 1991 | A |
4981475 | Haindl | Jan 1991 | A |
4997421 | Palsrok et al. | Mar 1991 | A |
5024665 | Kaufman | Jun 1991 | A |
5037397 | Kalt et al. | Aug 1991 | A |
5037398 | Buchanan | Aug 1991 | A |
5037405 | Crosby | Aug 1991 | A |
5074847 | Greenwell et al. | Dec 1991 | A |
D323390 | Paine et al. | Jan 1992 | S |
5084026 | Shapiro | Jan 1992 | A |
5098048 | Chen | Mar 1992 | A |
5105807 | Kahn et al. | Apr 1992 | A |
5112313 | Sallee | May 1992 | A |
5116324 | Brierley et al. | May 1992 | A |
5120320 | Fayngold | Jun 1992 | A |
5135506 | Gentelia et al. | Aug 1992 | A |
5137519 | Littrell et al. | Aug 1992 | A |
5147322 | Bowen et al. | Sep 1992 | A |
5156641 | White | Oct 1992 | A |
5163913 | Rantanen-Lee et al. | Nov 1992 | A |
5167630 | Paul | Dec 1992 | A |
5192273 | Bierman et al. | Mar 1993 | A |
5192274 | Bierman | Mar 1993 | A |
5195981 | Johnson | Mar 1993 | A |
5215532 | Atkinson | Jun 1993 | A |
5238010 | Grabenkort et al. | Aug 1993 | A |
5248306 | Clark et al. | Sep 1993 | A |
5263943 | Vanderbrook | Nov 1993 | A |
5267967 | Schneider | Dec 1993 | A |
5290248 | Bierman | Mar 1994 | A |
5306253 | Brimhall | Apr 1994 | A |
5306256 | Jose | Apr 1994 | A |
D347060 | Bierman | May 1994 | S |
5314411 | Bierman et al. | May 1994 | A |
5328487 | Starchevich | Jul 1994 | A |
5330438 | Gollobin et al. | Jul 1994 | A |
5336195 | Daneshvar | Aug 1994 | A |
5341411 | Hashimoto | Aug 1994 | A |
5344414 | Lopez et al. | Sep 1994 | A |
5354282 | Bierman | Oct 1994 | A |
5356379 | Vaillancourt | Oct 1994 | A |
5356391 | Stewart | Oct 1994 | A |
5370627 | Conway | Dec 1994 | A |
5380293 | Grant | Jan 1995 | A |
5380294 | Persson | Jan 1995 | A |
5380301 | Prichard et al. | Jan 1995 | A |
5382239 | Orr et al. | Jan 1995 | A |
5382240 | Lam | Jan 1995 | A |
5395344 | Beisang, III et al. | Mar 1995 | A |
5413120 | Grant | May 1995 | A |
5413562 | Swauger | May 1995 | A |
D359120 | Sallee et al. | Jun 1995 | S |
5456671 | Bierman | Oct 1995 | A |
5470321 | Forster et al. | Nov 1995 | A |
D364922 | Bierman | Dec 1995 | S |
5484425 | Fischell et al. | Jan 1996 | A |
5496283 | Alexander | Mar 1996 | A |
5507535 | McKamey et al. | Apr 1996 | A |
5531695 | Swisher | Jul 1996 | A |
D375355 | Bierman | Nov 1996 | S |
D375356 | Bierman | Nov 1996 | S |
5577516 | Schaeffer | Nov 1996 | A |
5578013 | Bierman | Nov 1996 | A |
D377831 | Bierman | Feb 1997 | S |
5605546 | Wolzinger et al. | Feb 1997 | A |
5620427 | Werschmidt et al. | Apr 1997 | A |
5626565 | Landis et al. | May 1997 | A |
5643217 | Dobkin | Jul 1997 | A |
5681290 | Alexander | Jul 1997 | A |
5664581 | Ashley | Sep 1997 | A |
5685859 | Kornerup | Nov 1997 | A |
5686096 | Khan et al. | Nov 1997 | A |
5690616 | Mogg | Nov 1997 | A |
5690617 | Wright | Nov 1997 | A |
5693032 | Bierman | Dec 1997 | A |
5702371 | Bierman | Dec 1997 | A |
5722959 | Bierman | Mar 1998 | A |
5728053 | Calvert | Mar 1998 | A |
5755225 | Hutson | May 1998 | A |
5800402 | Bierman | Sep 1998 | A |
5800410 | Gawreluk | Sep 1998 | A |
5810781 | Bierman | Sep 1998 | A |
5814021 | Balbierz | Sep 1998 | A |
D399954 | Bierman | Oct 1998 | S |
5827230 | Bierman | Oct 1998 | A |
5827239 | Dillon et al. | Oct 1998 | A |
5833666 | Davis et al. | Nov 1998 | A |
5833667 | Bierman | Nov 1998 | A |
5855591 | Bierman | Jan 1999 | A |
5885251 | Luther | Mar 1999 | A |
5885254 | Matyas | Mar 1999 | A |
5897519 | Shesol et al. | Apr 1999 | A |
5947931 | Bierman | Sep 1999 | A |
6050934 | Mikhail et al. | Apr 2000 | A |
D425619 | Bierman | May 2000 | S |
6099509 | Brown, Jr. et al. | Aug 2000 | A |
6113577 | Hakky et al. | Sep 2000 | A |
6132398 | Bierman | Oct 2000 | A |
6132399 | Shultz | Oct 2000 | A |
6139532 | Howell et al. | Oct 2000 | A |
D433503 | Powers et al. | Nov 2000 | S |
6213979 | Bierman | Apr 2001 | B1 |
6213996 | Jepson et al. | Apr 2001 | B1 |
6224571 | Bierman | May 2001 | B1 |
6228064 | Abita et al. | May 2001 | B1 |
6231547 | O'Hara | May 2001 | B1 |
6231548 | Bassett | May 2001 | B1 |
6258066 | Urich | Jul 2001 | B1 |
6270086 | Lloyd | Aug 2001 | B1 |
6283945 | Bierman | Sep 2001 | B1 |
6290676 | Bierman | Sep 2001 | B1 |
6332874 | Eliasen et al. | Dec 2001 | B1 |
6361523 | Bierman | Mar 2002 | B1 |
6375639 | Duplessie et al. | Apr 2002 | B1 |
6413240 | Bierman et al. | Jul 2002 | B1 |
6428515 | Bierman et al. | Aug 2002 | B1 |
6428516 | Bierman | Aug 2002 | B1 |
6436073 | Von Teichert | Aug 2002 | B1 |
6447485 | Bierman | Sep 2002 | B2 |
6447486 | Tollini | Sep 2002 | B1 |
6471676 | DeLegge et al. | Oct 2002 | B1 |
6482183 | Pausch et al. | Nov 2002 | B1 |
6491664 | Bierman | Dec 2002 | B2 |
6500154 | Hakky et al. | Dec 2002 | B1 |
D469530 | Gomez | Jan 2003 | S |
D470936 | Bierman | Feb 2003 | S |
6517522 | Bell et al. | Feb 2003 | B1 |
6551285 | Bierman | Apr 2003 | B1 |
6572588 | Bierman et al. | Jun 2003 | B1 |
6582403 | Bierman et al. | Jun 2003 | B1 |
6616635 | Bell et al. | Sep 2003 | B1 |
6626890 | Nguyen et al. | Sep 2003 | B2 |
6652487 | Cook | Nov 2003 | B1 |
6663600 | Bierman et al. | Dec 2003 | B2 |
6673046 | Bierman et al. | Jan 2004 | B2 |
6689104 | Bierman | Feb 2004 | B2 |
D492411 | Bierman | Jun 2004 | S |
6770055 | Bierman et al. | Aug 2004 | B2 |
6786892 | Bierman | Sep 2004 | B2 |
6809230 | Hancock et al. | Oct 2004 | B2 |
6824527 | Gollobin | Nov 2004 | B2 |
6827705 | Bierman | Dec 2004 | B2 |
6827706 | Tollini | Dec 2004 | B2 |
6827707 | Wright et al. | Dec 2004 | B2 |
6834652 | Altman | Dec 2004 | B2 |
6837875 | Bierman | Jan 2005 | B1 |
6866652 | Bierman | Mar 2005 | B2 |
D503977 | Bierman | Apr 2005 | S |
6951550 | Bierman | Oct 2005 | B2 |
6972003 | Bierman et al. | Dec 2005 | B2 |
6979320 | Bierman | Dec 2005 | B2 |
6981969 | Chavez et al. | Jan 2006 | B2 |
7014627 | Bierman | Mar 2006 | B2 |
7018362 | Bierman et al. | Mar 2006 | B2 |
7070580 | Nielsen | Jul 2006 | B2 |
7090660 | Roberts et al. | Aug 2006 | B2 |
D528206 | Bierman | Sep 2006 | S |
7144387 | Millerd | Dec 2006 | B2 |
7153291 | Bierman | Dec 2006 | B2 |
7354421 | Bierman | Apr 2008 | B2 |
7491190 | Bierman et al. | Feb 2009 | B2 |
7935083 | Bierman et al. | May 2011 | B2 |
20020068904 | Bierman et al. | Jun 2002 | A1 |
20020099360 | Bierman | Jul 2002 | A1 |
20020111601 | Thompson | Aug 2002 | A1 |
20020133121 | Bierman | Sep 2002 | A1 |
20030055382 | Schaeffer | Mar 2003 | A1 |
20030163096 | Swenson et al. | Aug 2003 | A1 |
20030181870 | Bressler et al. | Sep 2003 | A1 |
20030229313 | Bierman | Dec 2003 | A1 |
20040102736 | Bierman | May 2004 | A1 |
20040111067 | Kirchhofer | Jun 2004 | A1 |
20040204685 | Wright et al. | Oct 2004 | A1 |
20050096606 | Millerd | May 2005 | A1 |
20050182367 | Walborn | Aug 2005 | A1 |
20050215953 | Rossen | Sep 2005 | A1 |
20050288635 | Davis et al. | Dec 2005 | A1 |
20060015076 | Heinzerling et al. | Jan 2006 | A1 |
20060064063 | Bierman | Mar 2006 | A1 |
20060079740 | Silver et al. | Apr 2006 | A1 |
20060135944 | Bierman | Jun 2006 | A1 |
20060184127 | Bierman | Aug 2006 | A1 |
20060184129 | Bierman | Aug 2006 | A1 |
20060217669 | Botha | Sep 2006 | A1 |
20060247577 | Wright | Nov 2006 | A1 |
20060264836 | Bierman | Nov 2006 | A1 |
20060270994 | Bierman | Nov 2006 | A1 |
20060270995 | Bierman | Nov 2006 | A1 |
20070016166 | Thistle | Jan 2007 | A1 |
20070083153 | Haar | Apr 2007 | A1 |
20070250021 | Brimhall et al. | Oct 2007 | A1 |
20080045905 | Chawki | Feb 2008 | A1 |
20080300543 | Abriles et al. | Dec 2008 | A1 |
20100049139 | Kiyono et al. | Feb 2010 | A1 |
20100298777 | Nishtala | Nov 2010 | A1 |
20120265147 | Andino et al. | Oct 2012 | A1 |
20130079723 | Andino | Mar 2013 | A1 |
Number | Date | Country |
---|---|---|
1311977 | Dec 1992 | CA |
1318824 | Jun 1993 | CA |
2 341 297 | Apr 1975 | DE |
0 114 677 | May 1989 | EP |
0 356 683 | Jul 1989 | EP |
0 169 704 | Nov 1989 | EP |
0 367 549 | May 1990 | EP |
0 263 789 | Jun 1991 | EP |
0 247 590 | Dec 1993 | EP |
0 720 836 | Jul 1996 | EP |
2922458 | Apr 2009 | FR |
2 063 679 | Jun 1981 | GB |
2 086 466 | May 1982 | GB |
2 178 811 | Feb 1987 | GB |
WO 9005559 | May 1990 | WO |
9421319 | Sep 1994 | WO |
9715337 | May 1997 | WO |
9955409 | Nov 1999 | WO |
2004016309 | Feb 2004 | WO |
09032008 | Mar 2009 | WO |
10132837 | Nov 2010 | WO |
Entry |
---|
“Definition of Battery.” Oxford Dictionaries. http://www.oxforddictionaries.com/us/definition/american_english/battery. |
International Search Report from PCT/US2007/077302 dated Mar. 28, 2008. |
National Patent Services, Search Report re Patent Validity Study of U.S. Pat. No. 5,827,230, pp. MDG 001319-MDG 001320, May 23, 2006. |
Cravens, et al., Urinary Catheter Management, American Family Physician, vol. 61, No. 2, pp. MDG 000273-MDG 000282, Jan. 15, 2000. |
Dale® Foley Catheter Holder brochure, pp. MDG 000344-MDG 000346, 2002. |
Grip-LokTM Universal Tubing Securement brochure, pp. MDG 000348-MDG 000349, undated. |
M.C. Johnson Co., Cath-Secure® brochure, pp. MDG 000357-MDG 000360, undated. |
Grip-Lok Universal Tubing Securement brochure, pp. MDG 000364-MDG 000366, 2005-2006. |
Expert Discusses Strategies to Prevent CAUTIs, Infection Control Today, pp. MDG 000603-MDG-000609, Jun. 2005. |
U.S. Appl. No. 13/577,425, filed Sep. 17, 2012, Non-Final Office Action of dated May 21, 2015. |
U.S. Appl. No. 13/577,425, filed Sep. 17, 2012, Final Office Action of dated Sep. 8, 2015. |
U.S. Appl. No. 13/577,425, filed Sep. 17, 2012, Advisory Action of dated Dec. 4, 2015. |
U.S. Appl. No. 13/498,121, filed Jul. 3, 2012 Final Office Action dated Nov. 5, 2015. |
U.S. Appl. No. 13/320,381, filed Feb. 27, 2012 Non-Final Office Action dated Aug. 26, 2015. |
U.S. Appl. No. 13/320,381, filed Feb. 27, 2012 Final Office Action dated Dec. 17, 2015. |
PCT/US2011/026897 filed Mar. 2, 2011 International Search Report dated Apr. 26, 2011. |
PCT/US2010/051664 filed Oct. 6, 2010 International Search Report and Written Opinion dated Dec. 2, 2010. |
PCT/US2010/035004 filed May 14, 2010 International Search Report and Written Opinion dated Jul. 21, 2010. |
AU 2010303477 filed Oct. 6, 2010 Examiner's Search Report dated Oct. 22, 2015. |
U.S. Appl. No. 13/320,381, filed Feb. 27, 2012 Non-Final Office Action dated Jul. 29, 2016. |
U.S. Appl. No. 13/498,121, filed Jul. 3, 2012 Non-Final Office Action dated Jun. 3, 2016. |
Number | Date | Country | |
---|---|---|---|
20120232490 A1 | Sep 2012 | US |
Number | Date | Country | |
---|---|---|---|
61452014 | Mar 2011 | US |